Skip to main content
. 2020 Oct 23;10:18179. doi: 10.1038/s41598-020-74885-1

Figure 3.

Figure 3

(A) Raman spectra for (a) IBU (b) 12% PCL mat (without drug) (c) 12% PCL-IBU (d) 10% PCLSW-1 (e) 10% PCLSW-2 (f) 12% PCLSW- 1 (g) 12% PCLSW-2. (Peak values in Red shows IBU peaks) and (B) FTIR spectra of (a) IBU (b) 12% PCL mat (without drug) (c) 12% PCL-IBU (d) 10% PCLSW- 1 (e) 10% PCLSW- 2 (f) 12% PCLSW- 1 (g) 12% PCLSW- 2.